Nasal polyps are benign growths occurring inside the paranasal
sinuses and in the lining of the nose. Generally, it is characterized
as a teardrop shaped and yellowish brown or pink in color. The size
of the polyps may vary and can be clustered or may grow alone. These
can cause severe infections and breathing difficulties, causing sleep
apnea in some cases. The cause of nasal polyps can be due to asthma,
allergic infections, sinus infections, cystic fibrosis, etc. There
are no particular symptoms that develop but an inflammation in the
lining of the nose can occur.
To
Access the Free Sample Report:
https://www.coherentmarketinsights.com/insight/request-sample/2775
Global
Nasal Polyps Treatment Market Drivers
Key players are constantly focused on developing novel approaches for
treatment of nasal polyps, which is expected to impel the global
nasal polyps’s treatment market growth. For instance, in April
2018, Intersect ENT Inc. launched a product, SINUVA. It is a sinus
implant and used for treating nasal polyps. It is a new way of
treatment in patients with the past sinus surgeries. This implant
contains 1.35 mg mometasone furoate which is delivered, directly to
the polyps. It is implanted for a definite period of time (90 days).
Furthermore, in June 2019, Novartis AG revealed the phase III
clinical trial study of Xolair, Omalizumab. It is a monoclonal
antibody used for treating nasal polyps. It tends to target and block
the immunoglobulin E. It was observed that the medication was
generally well-tolerated in patients. Hence, such developments of
treatment for nasal polyps are expected to fuel the global nasal
polyps treatment market growth.
Increasing approvals from regulatory bodies related to nasal polyps
treatment is expected to drive the global nasal polyps treatment
market growth. For instance, in June 2019, Dupixent received an
approval from the U.S. Food & Drug Administration (FDA) for
treating with nasal polyps. It was manufactured by Sanofi in
partnership with Regeneron Pharmaceuticals Inc. It is the first
treatment that got approved for chronic rhinosinusitis with nasal
polyps. It is used when the oral steroids are unable to control the
inflammation and to avoid the surgical method. Hence, such approvals
are expected to impact positively on the global nasal polyps
treatment market growth.
Global
Nasal Polyps Treatment Market Regional Analysis
North America is expected to hold a dominant position in the global
nasal polyps treatment market. Factors such as higher prevalence of
asthma is expected to be a major contributor in the North America’s
nasal polyps treatment market growth. Nasal polyps are triggered due
to asthma and also at the same time nasal polyps can cause asthma.
For instance, according to American Academy of Allergy, Asthma &
Immunology 2017, published data, around 28% to 40% patients with
nasal polyps are diagnosed with asthma. According to the same source,
around 19% to 39% patients get nasal polyps who are already suffering
from asthma. Such increasing prevalence may increase the demand for
treatment of nasal polyps thereby expected to propel the global nasal
polyps treatment market growth.
Global
Nasal Polyps Treatment Market Key Players
Some of the major players operating in the global nasal polyps
treatment market include, Intersect ENT Inc., GlaxoSmithKline Plc,
Merck Sharp and Dohme Corp, Teva Branded Pharmaceutical Products R
and D Inc., Norton Waterford Ltd, Sanofi, Regeneron Pharmaceuticals
Inc., Fougera Pharmaceuticals Inc., Glenmark, and Taro
Pharmaceuticals Industries Ltd.
Global
Nasal Polyps Treatment Market Taxonomy
By
Drug
-
Fluticasone
-
Mometasone
-
Fluticasone
-
Beclomethasone
-
Prednisone
-
Others
By
Route of Administration
-
Oral
-
Nasal
-
Injectable
Get
Full Access of This Business Report:
https://www.coherentmarketinsights.com/ongoing-insight/nasal-polyps-treatment-market-2775
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment